A new overview of systematic reviews of published randomized control trials of mobile health apps found just 23 RCTs of currently-available apps have been conducted, and less than half of those showed a positive health effect from the app in question.
A group of researchers from the Centre for Research in Evidence-Based Practice at Bond University in Queensland, Australia conducted the review,...
Proteus Digital Health announced interim study results from a randomized control study of its Proteus Discover timed with the American College of Cardiology event, ACC.16, in Chicago this week. The study included 96 patients with uncontrolled hypertension and type 2 diabetes and showed that a majority of the patients using the digital offering achieved the blood pressure target at week four.
The...
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the studies, all of which involved children and adolescents, indicate a 144 percent increase in adherence for patients using the connected devices, a 14.9 percent increase in lung function and a 37...
A group of researchers that reviewed 25 studies has concluded that remote monitoring of patients with chronic heart disease cuts healthcare costs, improves quality of life and reduces the number of hospital admissions. The review included results from some 9.500 patients. It compared telephone and remote monitoring to standard care.
The group that used telephone support were patients who provided...
